Published online Oct 6, 2025. doi: 10.12998/wjcc.v13.i28.109536
Revised: June 4, 2025
Accepted: July 4, 2025
Published online: October 6, 2025
Processing time: 85 Days and 6.8 Hours
Uterine adenomyosis and pulmonary endometriosis are exceptionally rare in adolescents and can pose significant diagnostic challenges due to their nonspecific clinical presentation and imaging features, which may mimic malignancy. Here, we describe a case of adenomyosis-associated uterine rupture (secondary to hemorrhagic necrosis) and concurrent pulmonary endometriosis in a 16-year-old girl initially suspected of having advanced uterine cancer.
A 16-year-old girl presented with acute abdominal pain and oliguria. Imaging studies revealed a 15-cm ruptured uterine mass accompanied by hemoperitoneum and multiple pulmonary nodules suggestive of metastatic disease. Laboratory tests demonstrated severe anemia and markedly elevated tumor markers [cancer antigen (CA)-125: 1063 U/mL; CA-19-9: 1347 U/mL]. Emergency laparotomy revealed adenomyosis-associated uterine rupture secondary to hemorrhagic necrosis, with no macroscopic abnormalities in other organs. A total abdominal hysterectomy was performed. Histopathological analysis confirmed uterine ade
This case of an adolescent patient highlights how benign gynecological conditions can mimic malignancy, necessitating broad differential diagnoses despite alarming presentations.
Core Tip: This case underscores the considerable diagnostic challenges associated with rare presentations of uterine adenomyosis and pulmonary endometriosis in adolescent patients. The clinical overlap with malignancy underscores the need for a high index of suspicion and a multidisciplinary approach to ensure accurate diagnosis and timely intervention. As demonstrated here, early surgical management combined with appropriate postoperative medical therapy can lead to favorable outcomes, even in the context of severe and atypical diseases. This case reinforces the necessity of including benign etiologies in the differential diagnosis of presumed advanced-stage malignancies, particularly in young female patients.
